{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T18:40:20Z","timestamp":1721673620019},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Clinical Research Fund of the Tokyo Metropolitan Government","award":["R030303007"],"award-info":[{"award-number":["R030303007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s11060-023-04381-9","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T09:01:47Z","timestamp":1689238907000},"page":"657-662","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CHD5 gene variant predicts leptomeningeal metastasis after surgical resection of brain metastases of breast cancer"],"prefix":"10.1007","volume":"163","author":[{"given":"Ryohei","family":"Otani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daichi","family":"Sadato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoji","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohisa","family":"Yajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakura","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsaku","family":"Takayanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Takami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuro","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"key":"4381_CR1","doi-asserted-by":"publisher","first-page":"iv84","DOI":"10.1093\/annonc\/mdx221","volume":"28","author":"E Le Rhun","year":"2017","unstructured":"Le Rhun E, Weller M, Brandsma D, Van den Bent M, de Azambuja E, Henriksson R, Boulanger T, Peters S, Watts C, Wick W, Wesseling P, Ruda R, Preusser M, Board EE, Committee EG (2017) EANO-ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours. Ann Oncol 28:iv84\u2013iv. https:\/\/doi.org\/10.1093\/annonc\/mdx221","journal-title":"Ann Oncol"},{"key":"4381_CR2","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.18632\/oncotarget.5911","volume":"7","author":"BJ Scott","year":"2016","unstructured":"Scott BJ, Oberheim-Bush NA, Kesari S (2016) Leptomeningeal metastasis in breast cancer - a systematic review. Oncotarget 7:3740\u20133747. https:\/\/doi.org\/10.18632\/oncotarget.5911","journal-title":"Oncotarget"},{"key":"4381_CR3","doi-asserted-by":"publisher","first-page":"vdab162","DOI":"10.1093\/noajnl\/vdab162","volume":"3","author":"IA Tewarie","year":"2021","unstructured":"Tewarie IA, Jessurun CAC, Hulsbergen AFC, Smith TR, Mekary RA, Broekman MLD (2021) Leptomeningeal disease in neurosurgical brain metastases patients: a systematic review and meta-analysis. Neurooncol Adv 3:vdab162. https:\/\/doi.org\/10.1093\/noajnl\/vdab162","journal-title":"Neurooncol Adv"},{"key":"4381_CR4","doi-asserted-by":"publisher","unstructured":"Ilic I, Faron A, Heimann M, Potthoff AL, Schafer N, Bode C, Borger V, Eichhorn L, Giordano FA, Guresir E, Jacobs AH, Ko YD, Landsberg J, Lehmann F, Radbruch A, Herrlinger U, Vatter H, Schuss P, Schneider M (2021) Combined Assessment of Preoperative Frailty and Sarcopenia allows the prediction of overall survival in patients with Lung Cancer (NSCLC) and surgically treated Brain Metastasis. Cancers (Basel) 13. https:\/\/doi.org\/10.3390\/cancers13133353","DOI":"10.3390\/cancers13133353"},{"key":"4381_CR5","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/neuonc\/noz049","volume":"21","author":"RS Prabhu","year":"2019","unstructured":"Prabhu RS, Turner BE, Asher AL, Marcrom SR, Fiveash JB, Foreman PM, Press RH, Patel KR, Curran WJ, Breen WG, Brown PD, Jethwa KR, Grills IS, Arden JD, Foster LM, Manning MA, Stern JD, Soltys SG, Burri SH (2019) A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases. Neuro Oncol 21:1049\u20131059. https:\/\/doi.org\/10.1093\/neuonc\/noz049","journal-title":"Neuro Oncol"},{"key":"4381_CR6","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","volume":"18","author":"A Mahajan","year":"2017","unstructured":"Mahajan A, Ahmed S, McAleer MF, Weinberg JS, Li J, Brown P, Settle S, Prabhu SS, Lang FF, Levine N, McGovern S, Sulman E, McCutcheon IE, Azeem S, Cahill D, Tatsui C, Heimberger AB, Ferguson S, Ghia A, Demonte F, Raza S, Guha-Thakurta N, Yang J, Sawaya R, Hess KR, Rao G (2017) Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol 18:1040\u20131048. https:\/\/doi.org\/10.1016\/S1470-2045(17)30414-X","journal-title":"Lancet Oncol"},{"key":"4381_CR7","doi-asserted-by":"publisher","unstructured":"Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D (2017) Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC.3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 18:1049\u20131060. https:\/\/doi.org\/10.1016\/S1470-2045(17)30441-2","DOI":"10.1016\/S1470-2045(17)30441-2"},{"key":"4381_CR8","doi-asserted-by":"publisher","first-page":"e0255257","DOI":"10.1371\/journal.pone.0255257","volume":"16","author":"D Sadato","year":"2021","unstructured":"Sadato D, Hirama C, Kaiho-Soma A, Yamaguchi A, Kogure H, Takakuwa S, Ogawa M, Doki N, Ohashi K, Harada H, Oboki K, Harada Y (2021) Archival bone marrow smears are useful in targeted next-generation sequencing for diagnosing myeloid neoplasms. PLoS ONE 16:e0255257. https:\/\/doi.org\/10.1371\/journal.pone.0255257","journal-title":"PLoS ONE"},{"key":"4381_CR9","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA (2010) The genome analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20:1297\u20131303. https:\/\/doi.org\/10.1101\/gr.107524.110","journal-title":"Genome Res"},{"key":"4381_CR10","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"N Research","year":"2013","unstructured":"Cancer Genome Atlas, Research N, Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM (2013) The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet 45:1113\u20131120. https:\/\/doi.org\/10.1038\/ng.2764","journal-title":"Nat Genet"},{"key":"4381_CR11","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1726","author":"Q Li","year":"2021","unstructured":"Li Q, Jiang B, Guo J, Shao H, Del Priore IS, Chang Q, Kudo R, Li Z, Razavi P, Liu B, Boghossian AS, Rees MG, Ronan MM, Roth JA, Donovan KA, Palafox M, Reis-Filho JS, de Stanchina E, Fischer ES, Rosen N, Serra V, Koff A, Chodera JD, Gray NS, Chandarlapaty S (2021) INK4 tumor suppressor proteins mediate resistance to CDK4\/6 kinase inhibitors. Cancer Discov https\/\/. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-1726","journal-title":"Cancer Discov https\/\/"},{"key":"4381_CR12","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/S1470-2045(20)30556-8","volume":"22","author":"AJ Morgan","year":"2021","unstructured":"Morgan AJ, Giannoudis A, Palmieri C (2021) The genomic landscape of breast cancer brain metastases: a systematic review. Lancet Oncol 22:e7\u2013e. https:\/\/doi.org\/10.1016\/S1470-2045(20)30556-8","journal-title":"Lancet Oncol"},{"key":"4381_CR13","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1158\/0008-5472.CAN-13-3056","volume":"74","author":"V Kolla","year":"2014","unstructured":"Kolla V, Zhuang T, Higashi M, Naraparaju K, Brodeur GM (2014) Role of CHD5 in human cancers: 10 years later. Cancer Res 74:652\u2013658. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-3056","journal-title":"Cancer Res"},{"key":"4381_CR14","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1186\/bcr3182","volume":"14","author":"X Wu","year":"2012","unstructured":"Wu X, Zhu Z, Li W, Fu X, Su D, Fu L, Zhang Z, Luo A, Sun X, Fu L, Dong JT (2012) Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer. Breast Cancer Res 14:R73. https:\/\/doi.org\/10.1186\/bcr3182","journal-title":"Breast Cancer Res"},{"key":"4381_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248\u2013249. https:\/\/doi.org\/10.1038\/nmeth0410-248","journal-title":"Nat Methods"},{"key":"4381_CR16","doi-asserted-by":"publisher","first-page":"15977","DOI":"10.18632\/oncotarget.7434","volume":"7","author":"K Naraparaju","year":"2016","unstructured":"Naraparaju K, Kolla V, Zhuang T, Higashi M, Iyer R, Kolla S, Okawa ER, Blobel GA, Brodeur GM (2016) Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas. Oncotarget 7:15977\u201315985. https:\/\/doi.org\/10.18632\/oncotarget.7434","journal-title":"Oncotarget"},{"key":"4381_CR17","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.1002\/j.1460-2075.1995.tb00301.x","volume":"14","author":"G Berx","year":"1995","unstructured":"Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, van Roy F (1995) E-cadherin is a tumour\/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14:6107\u20136115","journal-title":"EMBO J"},{"key":"4381_CR18","doi-asserted-by":"publisher","unstructured":"Vos CB, Cleton-Jansen AM, Berx G, de Leeuw WJ, ter, Haar NT, van Roy F, Cornelisse CJ, Peterse JL, van de Vijver MJ (1997) E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 76: 1131\u20131133 https:\/\/doi.org\/10.1038\/bjc.1997.523","DOI":"10.1038\/bjc.1997.523"},{"key":"4381_CR19","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s10549-011-1682-0","volume":"129","author":"S Lee","year":"2011","unstructured":"Lee S, Ahn HK, Park YH, Nam DH, Lee JI, Park W, Choi DH, Huh SJ, Park KT, Ahn JS, Im YH (2011) Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations. Breast Cancer Res Treat 129:809\u2013817. https:\/\/doi.org\/10.1007\/s10549-011-1682-0","journal-title":"Breast Cancer Res Treat"},{"key":"4381_CR20","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1002\/cncr.27581","volume":"118","author":"NU Lin","year":"2012","unstructured":"Lin NU, Vanderplas A, Hughes ME, Theriault RL, Edge SB, Wong YN, Blayney DW, Niland JC, Winer EP, Weeks JC (2012) Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network. Cancer 118:5463\u20135472. https:\/\/doi.org\/10.1002\/cncr.27581","journal-title":"Cancer"},{"key":"4381_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clbc.2016.07.002","volume":"17","author":"A Morikawa","year":"2017","unstructured":"Morikawa A, Jordan L, Rozner R, Patil S, Boire A, Pentsova E, Seidman AD (2017) Characteristics and outcomes of patients with breast Cancer with Leptomeningeal Metastasis. Clin Breast Cancer 17:23\u201328. https:\/\/doi.org\/10.1016\/j.clbc.2016.07.002","journal-title":"Clin Breast Cancer"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04381-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04381-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04381-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T14:09:22Z","timestamp":1690898962000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04381-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["4381"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04381-9","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"31 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the ethics committee at Tokyo Metropolitan Komagome Hospital (No. 2631).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Patients signed informed consent regarding publishing their data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing interests"}}]}}